Further, skipping of the RTN4 exon 3 was demonstrated to increase cell proliferation of glioma cells38, and reduced inclusion of exon 6 of the ANXA7 gene was reported to promote glioblastoma progression35. This evidence concerns the gene ANXA7 and central nervous system cancer.